CORT
CORCEPT THERAPEUTICS INC
CORCEPT THERAPEUTICS INC (CORT) has 11 SEC Form 4 filings (28 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jul 9, 2026.
Insiders have net sold $16.5M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Joseph K. Belanoff
- Employees:500
- HQ:Menlo Park, CA, US
- IPO:2004-04-14
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$16.5M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$9.6B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Development Officer | Sale | 20,000 | $1.9M | Jul 8 | SEC ↗ | |
| See Remarks | Sale | 25,000 | $2.2M | Jul 6 | SEC ↗ | |
WILSON JAMES NFirst filing | Director | Sale | 10,000 | $832K | Jun 18 | SEC ↗ |
MAHONEY DAVID LFirst filing | Director | Sale | 20,000 | $1.7M | Jun 18 | SEC ↗ |
Mokari AtabakFirst filing | Chief Financial Officer | Sale | 40,000 | $3.2M | Jun 17 | SEC ↗ |
Guyer WilliamFirst filing | Chief Development Officer | Sale | 20,000 | $1.4M | Jun 4 | SEC ↗ |
Lyon Joseph DouglasFirst filing | See Remarks | Sale | 5,000 | $325K | May 29 | SEC ↗ |
Maduck SeanFirst filing | See Remarks | Sale | 75,000 | $4.9M | May 29 | SEC ↗ |
Related companies
CORCEPT THERAPEUTICS INC is in the Healthcare sector.